share

Afatinib Impurity 9 CAS NO 2413212-17-4


Unit Price:

CAS No.:2413212-17-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Afatinib Impurity 9 is a designated impurity standard used in the analytical profiling and quality control of the active pharmaceutical ingredient (API) Afatinib. This high-purity reference material is critical for ensuring the safety, efficacy, and regulatory compliance of the final drug product by accurately identifying and quantifying related substances. It is an essential tool for pharmaceutical R&D laboratories, quality assurance departments, and regulatory affairs teams involved in the development and manufacturing of oncology therapeutics.

Application

  • Pharmaceutical Reference Standard: Primary use as a certified impurity standard for the qualitative and quantitative analysis of Afatinib API and drug products.
  • Method Development and Validation: Critical for developing, optimizing, and validating stability-indicating analytical methods such as HPLC and UPLC.
  • Quality Control and Batch Release: Used in routine QC testing to monitor impurity levels and ensure batches meet stringent pharmacopeial (e.g., USP, EP) and ICH guidelines.
  • Stability Studies: Employed to identify and track degradation products formed under various stress conditions (e.g., heat, light, humidity) during drug stability testing.
  • Regulatory Submissions: Provides essential data for regulatory filings (e.g., FDA, EMA) to establish impurity profiles and justify specification limits.
  • Process Chemistry Research: Aids in understanding and controlling impurity formation during the synthesis and purification stages of Afatinib manufacturing.

Basic Information

Product Name Afatinib Impurity 9
CAS No. 2413212-17-4
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms Afatinib Related Compound 9; Afatinib Impurity; Afatinib Specified Impurity; (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide Impurity; Giotrif Impurity; Gilotrif Impurity
EINECS Contact for details

Quality Control

Every batch of Afatinib Impurity 9 is manufactured and controlled under a strict quality management system. Our products undergo rigorous identity, purity, and impurity profile testing using advanced analytical techniques (e.g., HPLC, MS, NMR) to ensure compliance with the highest standards for pharmaceutical reference materials. A comprehensive Certificate of Analysis (COA) detailing batch-specific results is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) or as indicated on the label or COA. The material should be kept in a dry environment and handled with appropriate precautions to prevent contamination.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Retention time corresponds to reference standard
Identification (MS) Mass spectrum conforms to structure
Purity (HPLC) ≥ 95.0%
Related Substances (HPLC) Individual unknown impurity: ≤ 1.0% Total impurities: ≤ 5.0%
Residual Solvents (GC) Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.